Mutated p53 results in altered type I interferon pathway expression and signaling in endometrial cancer.

Welp AM, Mabry AR, Lines CL, Thaker PH, Mutch DG, Mullen MM, Weber JD

Open source

DOI
10.1016/j.ygyno.2026.08.016
Published
2026 Sep 7
Container
Gynecologic oncology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ygyno.2026.08.016,
  title = {Mutated p53 results in altered type I interferon pathway expression and signaling in endometrial cancer.},
  author = {Welp AM and Mabry AR and Lines CL and Thaker PH and Mutch DG and Mullen MM and Weber JD},
  year = {2026},
  journal = {Gynecologic oncology},
  doi = {10.1016/j.ygyno.2026.08.016},
  url = {https://doi.org/10.1016/j.ygyno.2026.08.016}
}

RIS

TY  - JOUR
TI  - Mutated p53 results in altered type I interferon pathway expression and signaling in endometrial cancer.
AU  - Welp AM
AU  - Mabry AR
AU  - Lines CL
AU  - Thaker PH
AU  - Mutch DG
AU  - Mullen MM
AU  - Weber JD
PY  - 2026
JO  - Gynecologic oncology
DO  - 10.1016/j.ygyno.2026.08.016
UR  - https://doi.org/10.1016/j.ygyno.2026.08.016
ER  - 

APA

AM, W., AR, M., CL, L., PH, T., DG, M., MM, M., & JD, W. (2026). Mutated p53 results in altered type I interferon pathway expression and signaling in endometrial cancer.. Gynecologic oncology. https://doi.org/10.1016/j.ygyno.2026.08.016

Source records